Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02201784
Other study ID # jnmch2012
Secondary ID
Status Completed
Phase Phase 4
First received July 24, 2014
Last updated January 14, 2015
Start date December 2012
Est. completion date January 2014

Study information

Verified date January 2015
Source Aligarh Muslim University
Contact n/a
Is FDA regulated No
Health authority India: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the effects of two intrathecally administered drugs:0.5% levobupivacaine and0.75%Ropivacaine in spinal anesthesia


Description:

Bupivacaine is a highly cardiotoxic drug and also produces prolonged motor blockade.The newer drugs levobupivacaine and ropivacaine being comparatively less cardio and neurotoxic are preferred now a days.So, we conducted this prospective, randomized double blind study with an aim of comparing the efficacy and characteristics of these drugs.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date January 2014
Est. primary completion date January 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

1. American Society of Anesthesiologists (ASA) class I & II patients of either sex

2. Age between 18-60 years

Exclusion Criteria:

1. Patient's refusal.

2. Patients who have contraindications to spinal anaesthesia / Local anaesthetic drugs.

3. Patients having h/o diabetes, neurological and musculoskeletal diseases.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Levobupivacaine
Comparison of Equipotent doses
Ropivacaine
Comparison of equipotent doses

Locations

Country Name City State
India Jawaharlal Nehru medical college, AMU Aligarh Uttar Pradesh

Sponsors (1)

Lead Sponsor Collaborator
Aligarh Muslim University

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Other Pulse Rate, Mean Arterial Pressure, SpO2 Intragroup and intergroup variation compared 8 hours No
Primary Duration of Analgesia Defined as time for first analgesic request by the patient 8 hours No
Secondary Onset of Sensory Block at T10 level of sensory block was assessed every 5 minutes till the loss of sensation to pinprick, using 22-guage hypodermic needle with 2mm protrusion through guard. Assessments continued at 30 min intervals following the completion of surgery until normal sensation returned. 30 minutes No
Secondary Median Maximum Level of Sensory Blockade level of sensory block was assessed every 5 minutes till the loss of sensation to pinprick, using 22-guage hypodermic needle with 2mm protrusion through guard. Assessments continued at 30 min intervals following the completion of surgery until normal sensation returned. 8 hours No
Secondary Time to Maximum Cephalic Spread of Sensory Block 8 hours No
Secondary Onset of Motor Block to Bromage3 Motor block in the lower limbs was graded according to the modified Bromage scale (Grade 0 = No motor block, Grade 1 = Inability to raise extended leg, able to move knees and feet, Grade 2 = Inability to raise extended leg and move knee, able to move feet, Grade 3 = Complete motor block of the lower limbs). Thereafter, It was performed every 5 minutes till the attainment of MB grade 3 followed by every 30 minutes until complete recovery (MB grade0). 8 hours No
Secondary Duration of Motor Block Time when the Bromage score will be back to zero 8 hours No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05234801 - Retrospective Foot and Ankle Data Collection
Recruiting NCT02660658 - Optimal Single Dose Intrathecal Dexmedetomidine for Postoperative Analgesia N/A
Completed NCT03858465 - Comparison of Phenylephrine and Ephedrine in the Treatment of Hemodynamic Disorders After Spinal Anesthesia in the Elderly N/A
Completed NCT03899038 - Minimum Effective Dose of 0.5% Bupivacaine for Ultrasound-guided Spinal Anesthesia Using Taylor's Approach N/A
Completed NCT00988234 - Comparison of Two Position for Ultrasound Guided Lumbar Plexus and Sciatic Nerve Block N/A